IN2012DN01584A - - Google Patents
Info
- Publication number
- IN2012DN01584A IN2012DN01584A IN1584DEN2012A IN2012DN01584A IN 2012DN01584 A IN2012DN01584 A IN 2012DN01584A IN 1584DEN2012 A IN1584DEN2012 A IN 1584DEN2012A IN 2012DN01584 A IN2012DN01584 A IN 2012DN01584A
- Authority
- IN
- India
- Prior art keywords
- cosmetically
- peptides
- consequence
- care
- diseases
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/095—Oxytocins; Vasopressins; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4703—Inhibitors; Suppressors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200930501 | 2009-07-24 | ||
| US22876709P | 2009-07-27 | 2009-07-27 | |
| PCT/EP2010/004530 WO2011009626A1 (en) | 2009-07-24 | 2010-07-23 | Compounds which inhibit muscle contraction |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2012DN01584A true IN2012DN01584A (pl) | 2015-06-05 |
Family
ID=43498785
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN1584DEN2012 IN2012DN01584A (pl) | 2009-07-24 | 2010-07-23 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US8946166B2 (pl) |
| EP (1) | EP2456457B1 (pl) |
| JP (1) | JP5782439B2 (pl) |
| KR (1) | KR101757946B1 (pl) |
| CN (1) | CN102470160B (pl) |
| AU (1) | AU2010275688B2 (pl) |
| BR (1) | BR112012001322B1 (pl) |
| CA (1) | CA2768386A1 (pl) |
| ES (1) | ES2527022T3 (pl) |
| IN (1) | IN2012DN01584A (pl) |
| MX (1) | MX2012001077A (pl) |
| PL (1) | PL2456457T3 (pl) |
| TW (1) | TWI487533B (pl) |
| WO (1) | WO2011009626A1 (pl) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2473559C1 (ru) * | 2011-10-26 | 2013-01-27 | Общество с ограниченной ответственностью "Синейро" | Пептид аземиопсин, избирательно взаимодействующий с никотиновыми холинорецепторами мышечного типа и пригодный для использования в качестве мышечного релаксанта в медицине и косметологии |
| EP2649985A1 (en) * | 2012-04-13 | 2013-10-16 | Lipotec, S.A. | Compounds which inhibit neuronal exocytosis (III) |
| EP2649983A1 (en) * | 2012-04-13 | 2013-10-16 | Lipotec, S.A. | Compounds which inhibit neuronal exocytosis (II) |
| EP2649984A1 (en) * | 2012-04-13 | 2013-10-16 | Lipotec, S.A. | Compounds which inhibit neuronal exocytosis |
| ES2660901T3 (es) * | 2012-04-13 | 2018-03-26 | Lubrizol Advanced Materials, Inc. | Compuestos que inhiben la exocitosis neuronal (II) |
| WO2014015179A1 (en) * | 2012-07-20 | 2014-01-23 | Sophoro Biotechnologies, Llc | Carbohydrate esters as inducers for gene expression |
| HUE034308T2 (en) | 2013-03-21 | 2018-02-28 | Sanofi Aventis Deutschland | Preparation of hydantoin-containing peptide products |
| US10450343B2 (en) | 2013-03-21 | 2019-10-22 | Sanofi-Aventis Deutschland Gmbh | Synthesis of cyclic imide containing peptide products |
| US20150110908A1 (en) | 2013-10-21 | 2015-04-23 | Ocusoft, Inc. | Compositions, Kits, and Methods for Ameliorating Oculoplastic Post-Procedural Effects |
| US20160250298A1 (en) | 2013-11-01 | 2016-09-01 | Spherium Biomed S.L. | Inclusion bodies for transdermal delivery of therapeutic and cosmetic agents |
| CA2965525A1 (en) | 2014-10-31 | 2016-05-06 | Lubrizol Advanced Materials, Inc. | Thermoplastic polyurethane film for delivery of active agents to skin surfaces |
| EP3371238A1 (en) | 2015-11-05 | 2018-09-12 | Lubrizol Advanced Materials, Inc. | Thermoformable dual network hydrogel compositions |
| WO2017136600A1 (en) | 2016-02-04 | 2017-08-10 | ALASTIN Skincare, Inc. | Compositions and methods for invasive and non-invasive procedural skincare |
| WO2017197382A1 (en) * | 2016-05-13 | 2017-11-16 | Gardner Mary | Treating of side-effects resulting from chemodenervation |
| CA3087881A1 (en) | 2017-01-17 | 2018-07-26 | Michael David FORREST | Therapeutic inhibitors of the reverse mode of atp synthase |
| CA3099077A1 (en) | 2017-07-13 | 2019-01-17 | Michael David FORREST | Therapeutic modulators of the reverse mode of atp synthase |
| EP3661538A4 (en) | 2017-08-03 | 2021-07-14 | Alastin Skincare, Inc. | COMPOSITIONS AND PROCEDURES FOR IMPROVING SLEEPING SKIN AND BODY CONTOUR |
| CN107898658A (zh) * | 2017-12-13 | 2018-04-13 | 南昌师范学院 | 六胜肽祛皱增效原液组合物 |
| WO2020028694A1 (en) | 2018-08-02 | 2020-02-06 | ALASTIN Skincare, Inc. | Liposomal compositions and methods of use |
| CN108904414A (zh) * | 2018-10-10 | 2018-11-30 | 广州科盈化妆品有限公司 | 一种快速祛皱眼霜 |
| EP4393502A2 (en) * | 2018-12-26 | 2024-07-03 | Skinmed Co., Ltd. | Acetylcholine receptor inhibitory peptides and uses thereof |
| EP3906013A1 (en) | 2019-01-02 | 2021-11-10 | The Procter & Gamble Company | Skin care compositions containing peptide compound and aphanothece sacrum exopolysaccharide extract |
| CN110426476A (zh) * | 2019-08-15 | 2019-11-08 | 珠海伊斯佳科技股份有限公司 | 一种化妆品中乙酰基六肽-8含量的测定方法 |
| CN114478297A (zh) * | 2020-11-12 | 2022-05-13 | 山东省科学院菏泽分院 | 一种扑炎痛的合成制备方法 |
| KR102584000B1 (ko) | 2021-01-19 | 2023-10-06 | 김기연 | 신경전달물질을 조절하는 펩타이드를 포함하는 스포츠 로션 조성물 |
| US11571378B2 (en) | 2021-01-22 | 2023-02-07 | The Procter & Gamble Company | Skin care composition and method of using the same |
| US11771637B2 (en) | 2021-01-22 | 2023-10-03 | The Procter & Gamble Company | Skin care composition and method of using the same |
| US20250325469A1 (en) | 2021-01-24 | 2025-10-23 | Michael David FORREST | Inhibitors of atp synthase - cosmetic and therapeutic uses |
| EP4501944A4 (en) * | 2022-03-28 | 2025-10-08 | Shenzhen Winkey Tech Co Ltd | POLYPEPTIDE AND COSMETIC COMPOSITION OR PHARMACEUTICAL COMPOSITION AND THEIR USE |
| CN116003518B (zh) * | 2023-01-10 | 2023-09-29 | 深圳市维琪科技股份有限公司 | 经设计的肽及其组合物和用途 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6169074B1 (en) | 1996-03-18 | 2001-01-02 | The Regents Of The University Of California | Peptide inhibitors of neurotransmitter secretion by neuronal cells |
| US6780413B2 (en) | 1996-09-19 | 2004-08-24 | The United States Of America As Represented By The Department Of Health And Human Services | Immunotoxin (mAB-RICIN) for the treatment of focal movement disorders |
| ES2160485B1 (es) | 1999-04-23 | 2002-05-16 | Lipotec Sa | Peptidos inhibidores de la exocitosis neuronal, composiciones cosmeticas y farmaceuticas que los contienen. |
| US7964630B2 (en) | 2004-11-02 | 2011-06-21 | Dsm Ip Assets B.V. | Topical application agents against mimic and age-related wrinkles |
-
2010
- 2010-07-23 JP JP2012520960A patent/JP5782439B2/ja active Active
- 2010-07-23 CA CA2768386A patent/CA2768386A1/en not_active Abandoned
- 2010-07-23 EP EP10736634.6A patent/EP2456457B1/en active Active
- 2010-07-23 AU AU2010275688A patent/AU2010275688B2/en active Active
- 2010-07-23 PL PL10736634T patent/PL2456457T3/pl unknown
- 2010-07-23 ES ES10736634.6T patent/ES2527022T3/es active Active
- 2010-07-23 WO PCT/EP2010/004530 patent/WO2011009626A1/en not_active Ceased
- 2010-07-23 IN IN1584DEN2012 patent/IN2012DN01584A/en unknown
- 2010-07-23 KR KR1020127004661A patent/KR101757946B1/ko active Active
- 2010-07-23 US US13/384,557 patent/US8946166B2/en active Active
- 2010-07-23 CN CN201080032189.2A patent/CN102470160B/zh active Active
- 2010-07-23 BR BR112012001322-0A patent/BR112012001322B1/pt active IP Right Grant
- 2010-07-23 TW TW099124330A patent/TWI487533B/zh not_active IP Right Cessation
- 2010-07-23 MX MX2012001077A patent/MX2012001077A/es active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| ES2527022T3 (es) | 2015-01-19 |
| TW201116289A (en) | 2011-05-16 |
| BR112012001322B1 (pt) | 2022-05-03 |
| WO2011009626A1 (en) | 2011-01-27 |
| JP5782439B2 (ja) | 2015-09-24 |
| BR112012001322A2 (pt) | 2020-08-11 |
| AU2010275688B2 (en) | 2014-06-19 |
| US20120121675A1 (en) | 2012-05-17 |
| AU2010275688A1 (en) | 2012-02-02 |
| CN102470160B (zh) | 2015-03-18 |
| CA2768386A1 (en) | 2011-01-27 |
| MX2012001077A (es) | 2012-06-12 |
| TWI487533B (zh) | 2015-06-11 |
| KR20120104159A (ko) | 2012-09-20 |
| KR101757946B1 (ko) | 2017-07-14 |
| EP2456457B1 (en) | 2014-10-22 |
| JP2013500245A (ja) | 2013-01-07 |
| US8946166B2 (en) | 2015-02-03 |
| CN102470160A (zh) | 2012-05-23 |
| HK1170415A1 (en) | 2013-03-01 |
| EP2456457A1 (en) | 2012-05-30 |
| PL2456457T3 (pl) | 2015-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2011010859A (es) | Peptidos utiles en el tratamiento y/o cuidado de la piel y/o cabello y su uso en composiciones cosmeticas o farmaceuticas. | |
| PH12012500756A1 (en) | Peptides used in the treatment and/or care of the skin, mucous membranes and/or hair and its use in cosmetic or pharmaceutical compositions | |
| MX2011008616A (es) | Peptidos utiles en el tratamiento y/o cuidado de la piel , mucosas y/o cuero cabelludo y su uso en composiciones cosmeticas o farmaceuticas. | |
| EA201290395A1 (ru) | Иммуномодулирующие полипептиды, полученные из il-2, и их применение для лечения рака и хронических инфекций | |
| EA201101243A1 (ru) | 3h-имидазо[4,5-c]пиридин-6-карбоксамиды в качестве противовоспалительных средств | |
| BRPI0913831B8 (pt) | peptídeo com a fórmula geral (i), seus estereoisômeros, suas misturas, ou seus sais cosmética ou farmaceuticamente aceitáveis, processo para a preparação de um peptídeo com a fórmula geral (i), seus estereoisômeros, suas misturas, ou seus sais cosmética ou farmaceuticamente aceitáveis e composição cosmética ou farmacêutica | |
| WO2016004093A3 (en) | Therapeutic compositions including galectin-3 inhibitors and uses thereof | |
| BR112012011332A2 (pt) | agentes direcionados para gadd45beta | |
| MY199967A (en) | Combinations of lsd1 inhibitors for use in the treatment of solid tumors | |
| TR201900542T4 (tr) | Ağrı ve/veya enflamasyon tedavisi için bileşimler. | |
| JP2016516023A5 (pl) | ||
| ES2572260T3 (es) | Péptidos útiles en el tratamiento y/o cuidado de la piel y/o membranas mucosas y su uso en composiciones cosméticas o farmacéuticas | |
| WO2015183963A3 (en) | Therapeutic compositions including redox-active parabenzoquinones and uses thereof | |
| MY171356A (en) | Polypeptides derived from il-2 having agonist activity for the therapy of cancer and chronic infections | |
| SG10201407403UA (en) | Treatments For Gastrointestinal Disorders | |
| CA2869599C (en) | Compounds which inhibit neuronal exocytosis (ii) | |
| EA201491321A1 (ru) | Фторметил-5,6-дигидро-4н-[1,3]оксазины | |
| WO2012080729A3 (en) | Casein kinase 1delta (ck1delta) inhibitors and their use in the treatment of neurodegenerative diseases such as tauopathies | |
| WO2015183995A3 (en) | Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof | |
| EA201492097A1 (ru) | 5-амино[1,4]тиазины в качестве ингибиторов бета-секретазы 1 | |
| WO2017164609A3 (ko) | 피부 재생 또는 상처 치료용 펩타이드 및 이의 용도 | |
| PH12014502623A1 (en) | Difluoro-hexahydro-cyclopentaoxazinyls and difluoro-hexahydro-benzooxazinyls as bace1 inhibitors | |
| CY1117854T1 (el) | Πεπτιδικη φαρμακοτεχνικη μορφη για τοπικη οφθαλμικη χρηση | |
| CY1115961T1 (el) | Ανυδρη μορφη κρυσταλλικης μηλεϊνικης ορβεπιταντης (orvepitant maleate) | |
| WO2010135521A3 (en) | Compositions and methods for the therapy and diagnosis of influenza |